M. B. Ranke Et Al. , "Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature," HORMONE RESEARCH , vol.68, no.2, pp.53-62, 2007
Ranke, M. B. Et Al. 2007. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature. HORMONE RESEARCH , vol.68, no.2 , 53-62.
Ranke, M. B., Lindberg, A., Price, D. A., Darendeliler, F. F., Albertsson-Wikland, K., Wilton, P., ... Reiter, E. O.(2007). Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature. HORMONE RESEARCH , vol.68, no.2, 53-62.
Ranke, Michael Et Al. "Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature," HORMONE RESEARCH , vol.68, no.2, 53-62, 2007
Ranke, Michael B. Et Al. "Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature." HORMONE RESEARCH , vol.68, no.2, pp.53-62, 2007
Ranke, M. B. Et Al. (2007) . "Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature." HORMONE RESEARCH , vol.68, no.2, pp.53-62.
@article{article, author={Michael B. Ranke Et Al. }, title={Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature}, journal={HORMONE RESEARCH}, year=2007, pages={53-62} }